US 10407445
Hepatitis C virus inhibitors
granted A61KA61K31/13A61K31/4178
Quick answer
US patent 10407445 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/13, A61K31/4178, A61K31/4184, A61K31/4188